Ultime notizie per Unity Software (NYSE:U) Azioni

Unity Software

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.

Unity Software Inc

SPROTT PHYSICAL URANIUM UNT

Sprott Physical Uranium Trust

ISHRS TRSRY BD 03 MNTH UCITS ETF A

AMUNDI MSCI EMERGING MAR II DIST ETF

MULT UNI ETF

AMND S&P 500 ESG ETF

Under Armour Inc

UACJ Corp

iShares MSCI UAE ETF

UNITED AMER HEALTHCARE CP by United American Healthcare Corp.

United American Healthcare Corp

United Airlines Holdings, Inc. - Common Stock

United Airlines Holdings Inc

UNITED AMERICAN CORP by United American Corp.

United American Corp

UA Multimedia Inc

United States Antimony Corporation Common Stock

United States Antimony Corp

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners LP

UNITED AMERICAN PETR by United American Petroleum Corp.

United American Petroleum Corp

Union Auction PCL ts Non-Voting Depository Receipt

Union Auction PCL

Innovator U.S. Equity Ultra Buffer ETF - April

United Arrows Ltd

UMBRA APPLIED TECHS GROUP by Umbra Applied Technologies Group, Inc.

Umbra Applied Technologies Group Inc

Innovator U.S. Equity Ultra Buffer ETF - August

AgEagle Aerial Systems, Inc. Common Stock

AgEagle Aerial Systems Inc

Unicly Mystic Axies Collection

UBS LUX MSCI EME ETF

Urbana Corp

UNITED BNCRP OF AL INC A by United Bancorporation of Alabama, Inc.

United Bancorp Of Alabama Inc

AMND GLOBAL CORP ETF

United Bancorp Inc

UBE INDUSTRIES LT ORD NEW by UBE CORPORATION

Ube Corp

Uber Technologies Inc

UBER TECHNOLOGIES ORD

UNITED BULLION EXCH INC by United Bullion Exchange, Inc.

United Security Bancshares - Common Stock

United Security Bancshares

UBI BLOCKCHAIN INTERNET by UBI BlockChain Internet Ltd.

UBI BlockChain Internet Ltd

GLOBAL X 0 TO 3 MNT US TB CL A ETF

UNION DE CERVECERIAS PERU by UNION DE CERVECERIAS PERUANAS BACKUS & JOHNSTON SA

UNITED BANK 144A

UNITED BANK GDR

U-BLOX HLDG AG NAMEN AKT by U-Blox Holding AG

u-Blox Holding AG

URBANIMMERSIVE INC by Urbanimmersive Inc.

Urbanimmersive Inc

VictoryShares Core Plus Intermediate Bond ETF

Urbanise.com Ltd

UNITED BNCSHS CLMBUS GRVE by United Bancshares, Inc.

United Bancshares Inc

Direxion Daily Robotics, Artificial Intelligence & Automation Index Bull 2X Shares

Ubiq

UBIQUITECH SOFTWARE CORP by Ubiquitech Software Corp.

Ubiquitech Software Corp

ProShares Ultra MSCI Brazil Capped

LS ISTX L3X UBE NR ETF

GraniteShares 2x Long UBER Daily ETF

UBS Group AG

KURE TECHNOLOGIES INC by Kure Technologies, Inc.

Kure Technologies Inc

UBISOFT ENTMT INC by UbiSoft Entertainment Inc.

Ubisoft Entertainment

UBISOFT ENTMT UNSP/ADR by UbiSoft Entertainment Inc.

United Bankshares Inc

UBS GROUP N ORD

ProShares Ultra 20+ Year Treasury

Unibright

UBU Holdings Inc

Unity Biotechnology Inc

UBIX.Network

Intercontinental Exchange (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) has outperformed the market over the past 10 years by 2.81% on an annualized basis producing an average annual return of 14.75%. Currently, Intercontinental Exchange has a market capitalization of $92.24 billion. 
Buying $100 In ICE: If an investor had bought $100 of ICE stock 10 years ago, it would be worth $399.49 today based on a price of $160.65 for ICE at the time of writing.
<h3>Intercontinental Exchange's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728592217_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $100 Invested In Intercontinental Exchange 10 Years Ago Would Be Worth Today

Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) has outperformed the market over the past 5 years by 42.63% on an annualized basis producing an average annual return of 56.65%. Currently, Viking Therapeutics has a market capitalization of $6.92 billion. 
Buying $1000 In VKTX: If an investor had bought $1000 of VKTX stock 5 years ago, it would be worth $9,757.81 today based on a price of $62.49 for VKTX at the time of writing.
<h3>Viking Therapeutics's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728592212_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VKTX

Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 46.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 29.01% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 9.59% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 8.16% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 5.91% at $1.85</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 5.63% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 5.46% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 5.23% at $0.23</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 4.95% at $0.19</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 4.62% at $0.06</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 9.41% at $0.17</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 6.33% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 5.19% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed down 4.53% at $0.55</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 4.01% at $4.45</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 3.15% at $0.45</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.07% at $1.59</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed down 3.02% at $0.04</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVSI

CXXIF

EAST

FFNTF

FUAPF

GNLN

ITHUF

NWVCF

OILFF

RMHB

RSSFF

TGIFF

TLRY

XXII

YCBD

Marijuana Stock Movers For October 10, 2024

WIIM

Inhibikase Therapeutics shares are trading higher after Point72 Asset Management reported an 8.4% passive stake in the company.

Third Quarter Preliminary Sales and Revenue
During the three months ended September 30, 2024, the Company sold approximately 17,350 attributable gold equivalent ounces1 and realized preliminary revenue2 of $44.7 million (21,123 attributable gold equivalent ounces and $41.3 million in revenue for the comparable period in 2023). Preliminary cost of sales, excluding depletion2 for the three months ended September 30, 2024, was $5.3 million resulting in cash operating margins1 of approximately $2,215 per attributable gold equivalent ounce1 ($4.7 million and $1,699 per attributable gold equivalent ounce for the comparable period in 2023, respectively).

Earnings

Guidance

SAND

Sandstorm Gold Royalties Announces Preliminary Q3 2024 Sales And Revenue; Sold ~17,350 Attributable Gold Equivalent Ounces And Realized Preliminary Revenue Of $44.7M; Preliminary Cost Of Sales, Excluding Depletion For The Three Months Ended September 30, 2024, Was $5.3M Resulting In Cash Operating Margins Of ~$2,215 Per Attributable Gold Equivalent Ounce

NLSP

NLS Pharmaceutics Regained Nasdaq Compliance

Citigroup analyst Brian Gong maintains Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) with a Buy and raises the price target from $66 to $72.

Price Target

Analyst Ratings

TCOM

Citigroup Maintains Buy on Trip.com Group, Raises Price Target to $72

AEHR

Aehr Test Systems shares are trading higher after the company reported better-than-expected Q1 financial results.

FrontView REIT 13G Filing Shows Millennium Management LLC Reported A 5.7% Stake In The Co As Of October 4, 2024

Aehr Test Systems Reiterates FY25 Guidance For Total Revenue Of At Least $70M (Est $71.20M) And Net Profit Before Taxes Of At Least 10% Of Revenue

As Of Oct 9, Phoenix Motor Is Not In Compliance With The Nasdaq Minimum Bid Price Requirement

OWLT

Owlet Regains NYSE Compliance

Improving market dynamics have provided relief, indicating confidence in both domestic and global economic conditions
Dun &amp; Bradstreet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNB#NYSE">DNB</a>), a leading global provider of business decisioning data and analytics, today released its Q4 2024 Global Business Optimism Insights report. The report, fielded in Q3 2024, found a 7% increase in business optimism quarter-over-quarter, driven by gradual easing of inflation rates and favorable borrowing conditions.
Nearly four in five businesses are expressing increased optimism in domestic and export orders, capital expenditures and financial risk due to a combination of easing financial pressures, shifts in monetary policies, robust regulatory frameworks and higher participation in sustainability initiatives.

Dun & Bradstreet Releases Its Q4 2024 Global Business Optimism Insights Report; Found A 7% Increase In Business Optimism QoQ, Driven By Gradual Easing Of Inflation Rates And Favorable Borrowing Conditions

Citigroup analyst Jason Gursky maintains Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) with a Buy and raises the price target from $160 to $176.

SAIC

Citigroup Maintains Buy on Science Applications Intl, Raises Price Target to $176

Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.02 by 250 percent. This is a 61.11 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $13.12 million which beat the analyst consensus estimate of $12.17 million by 7.82 percent. This is a 36.39 percent decrease over sales of $20.62 million the same period last year.

Earnings Beats

Aehr Test Systems Q1 2025 Adj EPS $0.07 Beats $0.02 Estimate, Sales $13.12M Beat $12.17M Estimate

Financing

Point72 Asset Management Reports 8.4% Passive Stake In Inhibikase Therapeutic

Based on the business that has been disrupted at the Hotel as a result of the labor activity, the Company anticipates that full-year 2024 total portfolio RevPAR growth will be 125 to 150 basis points lower, Adjusted EBITDAre will be $11 million to $13 million lower and Adjusted FFO Attributable to Common Stockholders per Diluted Share will be approximately $0.06 lower than the 2024 outlook as presented in the Company's second quarter earnings release. Approximately $6 million to $7 million of the total estimated Adjusted EBITDAre impact relates to business that was disrupted in the third quarter, with the remainder related to business that has been cancelled for the fourth quarter. The Company expects a portion of the group events that have been cancelled will be rebooked at the Hotel for a future period.
The estimated impact on the Company's prior full-year 2024 outlook is based only upon business that has been disrupted at the Hotel as a result of the labor activity and the Company expects to provide an updated 2024 outlook, including any changes in expectations for the remainder of its portfolio, as part of its third quarter earnings release on November 12, 2024.

Sunstone Hotel Investors RevPAR Growth To Drop 125-150 Basis Points In 2024 Due To Labor Disruptions, Adjusted EBITDAre Decrease By $11M-$13M, Adjusted FFO Down $0.06 Per Share; $6M-$7M Loss From Q3 Disruptions

Citigroup analyst Jason Gursky maintains RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) with a Neutral and raises the price target from $122 to $132.

Citigroup Maintains Neutral on RTX, Raises Price Target to $132

Sunstone Hotel Investors, Inc. (the "Company" or "Sunstone") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHO#NYSE">SHO</a>) today provided an update on recent operating activity for the third quarter and the estimated resulting impact on its previously provided full-year 2024 outlook.
Operations Update
The Company's operations for July and August 2024 were consistent with its prior expectations and reflect continued strength in group activity, an acceleration in business travel and an anticipated market-wide moderation in leisure demand in Maui. During the first two months of the quarter, the Company generated growth in total portfolio RevPAR and Total RevPAR, excluding The Confidante Miami Beach, of 2.4% and 6.3%, respectively, and Adjusted EBITDAre of approximately $37 million, which was in-line with the full-year 2024 outlook as presented in the Company's second quarter earnings release provided on August 7, 2024.

Sunstone Hotel Investors Announces During The First Two Months Of The Quarter, The Company Generated Growth In Total Portfolio RevPAR And Total RevPAR, Excluding The Confidante Miami Beach, Of 2.4% And 6.3%, Respectively, And Adjusted EBITDAre Of ~$37M, In-Line With The FY24 Outlook

AGMH

AGM Group Holdings Partners With Nowlit To Launch AGM Energy Corp For Expansion In AI And Crypto Markets In North America

Oppenheimer analyst Martin Yang maintained a Hold rating on Unity Software (U – Research Report) today. The company's shares closed yesterday at $2...

Oppenheimer Sticks to Its Hold Rating for Unity Software (U)

Unity Software: What Really Matters For Long-Term Growth

Unity Software: Leadership Focus On Profitability, Growth And Innovation To Drive An Awaited Comeback

Unity's Bullish Support May Finally Be Here, Downgrade To Hold

Overweight quality stocks with positive EPS revision - MS

Overweight quality stocks with positive EPS revisions - MS

Unity Software (U) stock started a sign of strength rally followed by a bullish flag—a classic setup for swing traders.

Unity Software (U) Stock: The Big Turnaround Or Just A Quick Swing Trade?

In this piece, I'm evaluating two gaming stocks: Unity Software ($U) and Roblox ($RBLX), a mid-cap and large-cap company respectively. Following my...

Comments

Unity Software

Notizie

Ultime notizie per Unity Software (NYSE:U) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO